Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Smithfield › NPI 1619911104
Hospital

Johnston Health Services Corporation

Johnston Health Services Corporation was paid $37.86M by Medicaid between Jan 2018 and Dec 2024, across 141 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.

33Billing provider infoJOHNSTON HEALTH SERVICES CORPORATION
SMITHFIELD, NC 27577
33aNPI1619911104assigned 06/15/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$37.86M
24GClaims749,814
24DCodes billed141
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#16 of 92
Median peer was paid$11.47M
This provider vs. median3.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201891,293$3.20M
201980,753$2.80M
202068,995$2.56M
202194,980$4.59M
2022122,895$7.52M
2023144,007$8.21M
2024incomplete146,891$8.99M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 28% 66,375 62,840 $10.56M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 27% 40,136 37,740 $10.30M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 10% 14,961 13,747 $3.80M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6.0% 14,434 13,622 $2.28M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.1% 2,603 2,449 $1.53M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.1% 12,005 11,540 $1.16M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.7% 19,171 17,954 $653K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 25,493 22,182 $603K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 61,685 54,450 $432K
80053 Comprehensive metabolic panel 1.1% 50,722 45,411 $417K
96375 Therapeutic injection; each additional sequential IV push 1.0% 14,729 12,504 $396K
70450 Computed tomography, head or brain; without contrast material <1% 2,406 2,255 $372K
129 more codes
71046 Radiologic examination, chest; 2 views <1% 8,942 $358K
J3490 Unclassified drugs <1% 102,987 $339K
96361 Intravenous infusion, hydration; each additional hour <1% 11,168 $321K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 13,760 $308K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 3,455 $252K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,767 $232K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,706 $193K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,068 $190K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 719 $181K
81025 <1% 17,890 $153K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 2,444 $151K
71045 Radiologic examination, chest; single view <1% 6,226 $148K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,857 $147K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,445 $139K
84484 <1% 15,571 $133K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 288 $128K
81001 <1% 38,060 $128K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 791 $124K
59025 Fetal non-stress test <1% 1,559 $102K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 724 $101K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,093 $99K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,570 $99K
83690 <1% 13,514 $96K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,906 $93K
87086 Culture, bacterial; quantitative colony count, urine <1% 11,126 $92K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 603 $88K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,694 $86K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,052 $81K
36415 Collection of venous blood by venipuncture <1% 27,610 $59K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,392 $59K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,386 $54K
J7050 Infusion, normal saline solution, 250 cc <1% 11,986 $47K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 294 $44K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 532 $42K
93458 <1% 56 $37K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 5,299 $35K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,013 $30K
83735 <1% 4,898 $30K
82728 <1% 3,925 $29K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,036 $28K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 628 $22K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,866 $19K
83550 <1% 3,660 $17K
83540 <1% 3,668 $13K
J2704 Injection, propofol, 10 mg <1% 3,189 $12K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,720 $12K
80048 Basic metabolic panel (calcium, ionized) <1% 1,681 $11K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 52 $11K
87081 <1% 1,607 $11K
96367 <1% 364 $11K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 303 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 244 $10K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 294 $9K
85610 <1% 2,779 $8K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 107 $7K
96417 <1% 173 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 22 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 161 $6K
84443 Thyroid stimulating hormone (TSH) <1% 458 $5K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 237 $5K
V2632 Posterior chamber intraocular lens <1% 450 $5K
82553 <1% 663 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,303 $4K
85027 <1% 907 $3K
83605 <1% 486 $3K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 148 $3K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 220 $3K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 196 $3K
82550 <1% 850 $3K
72125 Computed tomography, cervical spine; without contrast material <1% 14 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,033 $3K
85730 <1% 718 $3K
36591 <1% 146 $3K
71250 <1% 46 $2K
87070 <1% 478 $2K
J8597 Antiemetic drug, oral, not otherwise specified <1% 363 $2K
87040 <1% 179 $2K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 26 $2K
96415 <1% 79 $2K
82962 <1% 834 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 51 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 51 $2K
93320 <1% 26 $2K
80061 Lipid panel <1% 250 $2K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,175 $2K
83880 <1% 68 $1K
93325 <1% 26 $1K
99152 <1% 65 $1K
C1760 Closure device, vascular (implantable/insertable) <1% 73 $1K
82378 <1% 129 $1K
87420 <1% 69 $971.04
87205 <1% 337 $854.49
C1769 Guide wire <1% 16 $844.55
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 936 $785.18
86850 <1% 102 $738.16
81003 <1% 310 $677.60
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 861 $585.36
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 45 $577.82
88304 <1% 12 $537.68
00126 <1% 24 $500.49
84439 <1% 93 $434.42
J0690 Injection, cefazolin sodium, 500 mg <1% 44 $429.63
A9270 Non-covered item or service <1% 14,726 $380.48
85379 <1% 42 $343.84
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 59 $340.80
84702 <1% 30 $335.70
83655 <1% 18 $322.88
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 517 $300.58
J8540 Dexamethasone, oral, 0.25 mg <1% 237 $289.15
G0378 Hospital observation service, per hour <1% 19 $261.18
87186 <1% 39 $251.17
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 66 $241.84
86901 <1% 105 $214.15
86900 <1% 104 $214.15
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 65 $167.06
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 80 $165.17
87210 <1% 27 $157.34
82948 <1% 45 $136.33
85007 <1% 42 $115.83
82607 <1% 14 $110.33
90686 <1% 60 $100.05
83921 <1% 12 $82.04
J1644 Injection, heparin sodium, per 1000 units <1% 46 $48.22
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 22 $42.59
85018 <1% 13 $34.58
81002 <1% 12 $31.90
85651 <1% 13 $26.52
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 137 $2.30
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 17 $0.27

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCIELINSKI, KEVIN (CFO)